People with a history of hospitalization, diabetes, and higher body mass index were most likely to develop long COVID. (Photo: Shutterstock.com)
While debate continues about what, exactly, "long COVID" means, new research from the University of California, Los Angeles, suggests that about one-third of all people treated for coronavirus develop what is now known as Post-Acute Sequelae of COVID-19 (or PASC).
"Long COVID" is the term generally used to describe COVID-19 symptoms that linger for 60 days or longer after infection or hospitalization. UCLA researchers studied 1,038 COVID-19 patients, tracking their progress between April 2020 and February 2021. Of those, 309 patients (29.8%) developed long COVID with symptoms continuing past 60 or 90 days, based on patient questionnaire responses. The most persistent symptoms were fatigue (30%) and shortness of breath (15%) in hospitalized patients and loss of smell (16%) in outpatients.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
